What is the latest price of capmatinib in 2024?

Capmatinib is a targeted therapy for patients with non-small cell lung cancer with specific gene mutations, with significant efficacy and a relatively good safety profile.

What is the latest price of capmatinib in 2024?

Capmatinib has been marketed in China, but it has not yet been included in the list of drugs covered by the National Insurance. There are many specifications and brands of drugs on the market, and patients can buy capmatinib through formal channels. The price of capmatinib will be explained in detail next.

1. Lucius Pharmaceutical

The price of capmatinib (200mg*60 tablets) produced by Lucius Pharmaceutical in Laos is about 2,650 yuan per box.

2. Everest Pharmaceutical

Bangladesh Everest Pharmaceutical's product of the same specification (200mg*56 capsules) is sold at a slightly higher price, about 3,600 yuan per box.

3. Novartis Rahika brand

The price of capmatinib (200mg*60 tablets) of Novartis's Rahika brand is about 12,500 yuan.

4. Novartis, Switzerland

Novartis Pharmaceuticals in Switzerland provides two doses of capmatinib, 200mg*60 capsules and 150mg*60 capsules, and the combined price is about 31250 yuan per box.

What are the adverse effects of capmatinib?

Like other chemotherapy drugs, capmatinib has some potential adverse effects during use. According to the clinical trial and label data, the data are compiled as follows:

1. Peripheral edema

This is one of the most common adverse reactions of capmatinib treatment, which may manifest as edema in various parts of the body, especially swelling of the face, limbs and low-hanging parts of the body. The occurrence of peripheral edema may be related to the effect of drugs on the balance of water and salt in the body, which requires patients to pay close attention and timely feedback to the doctor to take corresponding management measures.

2. Nausea

Nausea is another common digestive discomfort that may be accompanied by a precursor to retching or vomiting. Nausea caused by capmatinib may affect the patient's appetite and nutrient intake, affecting overall health. Your doctor may recommend strategies such as eating small portions in small portions, avoiding greasy foods, and prescribing anti-nausea medications if necessary.

【Warm Tips】During the treatment with capmatinib, patients should pay close attention to the changes in their physical condition and report any uncomfortable symptoms to the doctor in time.